MicroRNAs targeting peroxisome proliferator-activated receptor (PPAR) gene are differentially expressed in low birth weight placentae
Placenta · 2023-08 · 139 · 51-60
DOI: 10.1016/j.placenta.2023.06.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Placenta, 2023-08. Verfasst von Deepali Sundrani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Mother and Child Health, Interactive Research School for Health Affairs, Bharati Vidyapeeth (Deemed to be University), Pune, 411043, India. Electroni…. Hauptthemen laut MEDLINE: MicroRNAs. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
INTRODUCTION: Peroxisome proliferator-activated receptors (PPARs) are activated by natural ligands like fatty acids and influence placental angiogenesis and pregnancy outcome. However, the underlying molecular mechanisms are not clear. This study aims to investigate the association of maternal and placental fatty acid levels with DNA methylation and microRNA regulation of PPARs in the placentae of women delivering low birth weight (LBW) babies. METHODS: This study includes 100 women delivering normal birth weight (NBW) baby and 70 women delivering LBW baby. Maternal and placental fatty acids levels were estimated by gas chromatograph. Gene promoter methylation and mRNA expression of PPARs was analyzed using Epitect Methyl-II PCR assay kit and RT-PCR respectively. Expression of miRNAs targeting PPAR mRNA were analyzed using a Qiagen miRCURY LNA PCR Array on RT-PCR. RESULTS: Placental docosahexaenoic acid (DHA) levels and placental mRNA expression of PPARα and PPARγ were lower (p < 0.05 for all) in the LBW group. Differential expression of miRNAs (upregulated miR-33a-5p and miR-22-5p; downregulated miR-301a-5p, miR-518d-5p, miR-27b-5p, miR-106a-5p, miR-21-5p, miR-548d-5p, miR-17-5p and miR-20a-5p) (p < 0.05 for all) was observed in the LBW group. Maternal and placental polyunsaturated fatty acids and total omega-3 fatty acids were positively associated while saturated fatty acids were negatively associated with expression of miRNAs (p < 0.05 for all). Placental expression of miRNAs were positively associated with birth weight (p < 0.05 for all). DISCUSSION: Our data suggests that maternal fatty acid status is associated with changes in the placental expression of miRNAs targeting PPAR gene in women delivering LBW babies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mother and Child Health, Interactive Research School for Health Affairs, Bharati Vidyapeeth (Deemed to be University), Pune, 411043, India. Electronic address: dips.sundrani@gmail.com.
- Mother and Child Health, Interactive Research School for Health Affairs, Bharati Vidyapeeth (Deemed to be University), Pune, 411043, India.
- Department of Obstetrics and Gynecology, Bharati Medical College and Hospital, Bharati Vidyapeeth (Deemed to be University), Pune, 411043, India.
Förderung
- Department of Biotechnology, Ministry of Science and Technology, India
Zitieren
APA
Sundrani, D., Karkhanis, A., Randhir, K., Panchanadikar, T., & Joshi, S. (2023). MicroRNAs targeting peroxisome proliferator-activated receptor (PPAR) gene are differentially expressed in low birth weight placentae. Placenta, 139, 51-60. https://doi.org/10.1016/j.placenta.2023.06.006
Vancouver
Sundrani D, Karkhanis A, Randhir K, Panchanadikar T, Joshi S. MicroRNAs targeting peroxisome proliferator-activated receptor (PPAR) gene are differentially expressed in low birth weight placentae. Placenta. 2023;139:51-60. doi:10.1016/j.placenta.2023.06.006
BibTeX
@article{Sundrani2023,
author = {Sundrani, Deepali and Karkhanis, Aishwarya and Randhir, Karuna and Panchanadikar, Tushar and Joshi, Sadhana},
title = {MicroRNAs targeting peroxisome proliferator-activated receptor (PPAR) gene are differentially expressed in low birth weight placentae},
journal = {Placenta},
year = {2023},
volume = {139},
pages = {51--60},
doi = {10.1016/j.placenta.2023.06.006}
}
EUVIMED